EUVIMEDEUVIMED entdecken
Crossref

MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustine

Sheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Souzan Najafi, Seyed Samad Hosseini, Mohammad Amini, Mohammad Amin Doustvandi, Nazila Mozammel, Behzad Baradaran, Amir Ali Mokhtarzadeh

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-024-03287-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Sheyda Jodeiry Zaer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs, Carmustine, Antineoplastic Agents, Alkylating. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As an aggressive malignancy, glioblastoma multiforme (GBM) is the most common type of brain tumor. The existing treatments have shown limited achievement in increasing the overall survival of patients. Therefore, identifying the key molecules involved in GBM will provide new potential therapeutic targets. Carmustine is an alkylating agent used as a supplementary therapeutic option for GBM. However, the extensive use of carmustine has been limited by uncertainty about its efficacy. MicroRNAs (miRNAs) are essential in post-transcriptional gene regulation. Many aberrantly expressed miRNAs have been detected in various types of human cancer, including GBM. In this study, we evaluated the potential therapeutic effect of miR-143 in combination with carmustine on GBM cells. A172 cells were transfected with miR-143 mimics and then treated with carmustine. To assess the cell viability, apoptosis induction, and cell cycle progression, the MTT assay, Annexin V/PI apoptosis assay, and flow cytometry were used, respectively. Furthermore, qRT-PCR assay was applied to evaluate the expression level of genes related to apoptosis. The obtained results evidenced that miR-143 transfection could promote the sensitivity of A172 cells to carmustine and enhance carmustine-induced apoptosis via modulating the expression levels of Caspase-3, Caspase-9, Bax, and Bcl-2. Also, our results revealed that combination therapy could effectively diminish cell cycle progression in A172 cells. In conclusion, these results confirmed that miR-143 could enhance carmustine-mediated suppression of cell proliferation and improve the chemosensitivity of A172 cells to this chemotherapeutic agent. Therefore, miR-143 combination therapy may be a promising GBM treatment approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMicroRNAsCarmustineAntineoplastic Agents, AlkylatingBrain NeoplasmsHumansCell Line, TumorApoptosisCell SurvivalGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmCell Proliferation

Stichwörter der Autor:innen

CancerChemotherapyCombination therapyGlioblastoma multiformemiR-143

Substanzen

MicroRNAsCarmustineMIRN143 microRNA, humanAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran. aghamaali@guilan.ac.ir.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ahad.mokhtarzadeh@gmail.com.

Zitieren

APA

Zaer, S. J., Aghamaali, M., Najafi, S., Hosseini, S. S., Amini, M., Doustvandi, M. A., Mozammel, N., Baradaran, B., & Mokhtarzadeh, A. A. (2025). MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustine. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03287-1

Vancouver

Zaer SJ, Aghamaali M, Najafi S, Hosseini SS, Amini M, Doustvandi MA, et al. MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustine. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03287-1

BibTeX
@article{Zaer2025,
  author = {Zaer, Sheyda Jodeiry and Aghamaali, Mahmoudreza and Najafi, Souzan and Hosseini, Seyed Samad and Amini, Mohammad and Doustvandi, Mohammad Amin and Mozammel, Nazila and Baradaran, Behzad and Mokhtarzadeh, Amir Ali},
  title = {MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustine},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-024-03287-1}
}
Kostenlos starten →